BOSTON & MONTREAL, April 01, 2025--enGene Holdings Inc. (Nasdaq: ENGN or "enGene" or the "Company"), a clinical-stage, ...

AstraZeneca (AZ) has announced that its Imfinzi (durvalumab) perioperative regimen has been approved by the US Food and Drug ...

Chronic urinary tract infections affect large numbers of women and, if left unchecked, can lead to much more serious conditions. So how can you start to treat them?

Imfinzi was generally well tolerated, and no new safety signals were observed in the neoadjuvant and adjuvant settings.

The US Food and Drug Administration (FDA) has approved AstraZeneca's human monoclonal antibody Imfinzi (durvalumab) with ...

Approval was based on improved survival outcomes vs platinum-based chemotherapy as demonstrated in the phase 3 NIAGARA study.

Terry Bradshaw, the NFL legend, faced double cancer diagnoses of bladder and skin cancer. This reshaped his life, making him ...

The promotional effort from Ferring features bladder cancer survivors sharing the news of a new treatment option.

FDA approved AstraZeneca's Imfinzi regimen for muscle-invasive bladder cancer, while the EU backed Calquence combo for untreated mantle cell lymphoma.

Fruits and plant extracts contain bioactive compounds that can help treat or prevent diseases. To characterize and understand ...

Dr. Janine Bowring, a naturopath based in Canada, who has over 25 years of clinical research under her belt, regularly shares ...

Approval of Imfinzi marks the first and only perioperative immunotherapy indicated for muscle-invasive bladder cancer.